Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Abiomed, Inc.
Abiomed Announces Revenue of $17.3 Million, Representing 8% Growth for Third Quarter of Fiscal 2009
February 20th, 2009
Abiomed, Inc. (NASDAQ: ABMD) Impella Revenue of $8.9 Million, Increased by 112%, Legacy Business Decreased by 29% Net Cash Used for Operating Activities of $2.5M Abiomed, Inc. (NASDAQ: ABMD), a leading provider of heart recovery products providing circulatory support to acute heart failure patients, announced third quarter of fiscal 2009 revenue of $17.3 million, up 8% compared to revenue of $16.0 million for the same period of fiscal 2008. Revenue for the nine months ended December 31, 2008 was $53.6 million, up 29% compared to revenue of $41.4 million in the first nine months of fiscal 2008. As of December 31, 2008, 163 U.S. hospitals had purchased Impella 2.5 for...
Source: Health Business Week (2009-02-20)
|
